ARWR
ARWR
US04280A1007
Arrowhead Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
8.84B EUR
11.5B EUR
8.81B EUR
9.12B EUR
Enterprise Value
8.36B EUR
12.47B EUR
9.66B EUR
9.36B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-12.73x
--
--
--
Price to Sales
13.2x
17.18x
14.17x
16.64x
Price to Book
19.03x
24.71x
14.36x
16.05x
EV/Revenue
12.49x
18.62x
15.52x
17.08x
EV/EBITDA
-41.68x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-0.55%
-0.65%
-0.58%
-1.46%
ende